LaNua Medical Raises €6M to Embolization Procedures LaNua Medical, a brand new medical technology startup and has closed seed funding of €6 million. The funding will advance the commercialization of the company‘s novel Ecore device. It is intended to enhance the safety, efficacy, and efficiency of embolization procedures applied to tackle DAVFs, hemorrhage, and a myriad of tumors. Visit: https://nextdigitalhealth.com/funding-news/lanua-medical-raises-e6m-to-embolization-procedures/ #LaNuamedical #funding #healthcare #DAVFs #Hemorrhage #tumors

Psychiatrist near San Francisco https://jmmdsf.com/forensic-neuropsychiatry Dr. Mueller is a neuropsychiatrist, a physician trained and board-certified separately in Neurology and Psychiatry. He sees patients with a range of cognitive, emotional and behavioral problems associated with stroke, head injury, dementia and brain tumors.

Forensic Neuropsychiatry https://jmmdsf.com/contact Dr. Mueller is a neuropsychiatrist, a physician trained and board-certified separately in Neurology and Psychiatry. He sees patients with a range of cognitive, emotional and behavioral problems associated with stroke, head injury, dementia and brain tumors.

Alentis Therapeutics Secures $181M to Advance Targeted Therapies for Solid Tumors Alentis Therapeutics, a leading biopharmaceutical company developing targeted treatments for cancer and fibrotic diseases, has secured $181.4 million in Series D funding round to develop targeted therapies for solid tumors. The financing round was spearheaded by OrbiMed, Novo Holdings, and JEITO, with significant contributions from new investors Longitude Capital, Frazier Life Sciences, Catalio Capital Management, Avego, and Piper Heartland Healthcare Capital. Existing investors RA Capital Management, MORNINGSIDE VENTURES LIMITED, Bpifrance, and BB Pureos, along with key institutional investors, participated in the round. Read more: https://nextdigitalhealth.com/funding-news/alentis-therapeutics-secures-181m-to-advance-targeted-therapies-for-solid-tumors/ #HealthcareNews #HealthcareInnovation #HealthcareTechnology #DrugDiscovery #FundingNews